Carcinoma of Unknown Primary — Trials

Carcinoma of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,156
Recruiting: 2,259
Ph III recruiting: 269
Growth YoY: +12.3%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,893)

clinicaltrialsPublishedShowing 1,601–1,650 of 1,959 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02585362	Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program	completed	N/A	52	Kantonsspital Winterthur KSWOTHER	1	Jan 11, 2019	clinicaltrials
NCT03176485	Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors	completed	N/A	45	University of ArizonaOTHER	1	Jan 4, 2019	clinicaltrials